Adverse reaction to Nexplanon®
نویسندگان
چکیده
منابع مشابه
Comment on 'Adverse reaction to Nexplanon®'.
The case referred to in Dr Chaudhry’s letter to the editor is interesting in view of the time after insertion and the nature of the breakdown in the overlying skin. While contamination is likely at the time of insertion of an implant, one would expect this to cause infection early and without an apparent symptom-free latent period. It is likely that the patient would have had some discomfort fr...
متن کاملAllergy to nexplanon®.
A 32-year-old woman presented requiring contraception. She had previously had an Implanon inserted, but this had been removed to allow her to become pregnant. Following her pregnancy she wished to use a long-term contraceptive method and requested another Implanon. Following insertion of a Nexplanon within 24 hours the site was red and inflamed. The redness was <0.5 mm around the outline of the...
متن کاملAdverse reaction to disopyramide.
A case is reported where the use of i.v. disopyramide for a supraventricular tachycardia resulted in a more serious ventricular dysrhythmia giving hypotension and this probably contributed to the development of a myocardial infarction. Attention is drawn to the possible risk.
متن کاملAn Unreported Clindamycin Adverse Reaction: Wrist Monoarthritis
Clindamycin is a lincosamide antibiotic which is approved for the treatment of anaerobic, streptococcal and staphylococcal infections. There has been an increased interest in the use of clindamycin since it achieves high intracellular levels in phagocytic cells, high levels in bone and appears to have an antitoxin effect against the toxin elaborating strains of streptococci and staphylococci. C...
متن کاملUnpredicted adverse reaction to omalizumab.
Despite promising reports of the use of omalizumab as add-on therapy in patients with systemic mastocytosis and recurrent anaphylaxis during specific venom immunotherapy (VIT), unpredicted adverse effects may lead to therapy failure. We present the case of a patient with systemic mastocytosis and Hymenoptera venom allergy who was administered omalizumab as add-on therapy to improve VIT tolerabi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Family Planning and Reproductive Health Care
سال: 2013
ISSN: 1471-1893,2045-2098
DOI: 10.1136/jfprhc-2013-100633